Ambrx Biopharma Inc - ADR Shares Close the Week 28.7% Lower - Weekly Wrap

Ambrx Biopharma Inc - ADR (AMAM) shares closed this week 28.7% lower than it did at the end of last week. The stock is currently down 33.2% year-to-date, down 64.6% over the past 12 months, and down 64.6% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 0.7%.

Trading Activity

  • Shares traded as high as $8.63 and as low as $6.03 this week.
  • Shares closed 73.3% below its 52-week high and 1.2% above its 52-week low.
  • Trading volume this week was 48.9% lower than the 10-day average and 50.2% lower than the 30-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at 0.0.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
  • MACD, a trend-following momentum indicator, indicates a downward trend.
  • The stock closed above its Bollinger band, indicating it may be overbought.

Market Comparative Performance

  • The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis
  • The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis

Per Group Comparative Performance

  • The company's stock price performance year-to-date lags the peer average by 13720.6%
  • The company's stock price performance over the past 12 months lags the peer average by 308.1%


This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.